Macrophage-capping protein (MCP) suppresses the UFMylation of PIR, leading to a reduction in GPX4 transcription [61]
When to speak to your GP Contact your GP or rheumatologist if you experience: A significant RA flare after starting Wegovy or changing dose Persistent nausea or vomiting that affects your ability to take oral RA medications consistently New or worsening joint symptoms that dont follow your usual flare pattern Dehydration symptoms (dark urine, reduced urine output, dizziness), particularly if you take methotrexate, which requires adequate hydration for kidney clearance Significant weight loss that might affect your RA medication dosing Stomach pain or GI symptoms that are worse than expected, especially if youre taking NSAIDs or corticosteroids alongside Wegovy Feelings of low mood, anxiety, or being overwhelmed by managing your condition Frequently asked questions Is Wegovy safe with rheumatoid arthritis
Available 24/7 We're here around the clock, seven days a week, with same-day appointments around your life and your schedule
Efficacy and safety of retatrutide in people with type 2 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 1b trial
doi:10.3390/nu5114521
DOI ISSN 2375-1924 Abstract Successful liver transplant is the only life-saving intervention for patients with end-stage liver disease (ESLD)